AMF-responsive doxorubicin loaded β-cyclodextrin-decorated superparamagnetic nanoparticles

An alternating magnetic field (AMF)-responsive controlled release system has been developed by the binding of mono-6-deoxy-6-( p -tolylsulfonyl)-β-cyclodextrin (βCD-Ts) onto amine-modified superparamagnetic iron oxide nanoparticles (MNP-NH 2 ), resulting in a MNP-βCD nanocarrier. The structural, che...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:New journal of chemistry 2018, Vol.42 (1), p.671-680
Hauptverfasser: Santos, Evelyn C. da S., Watanabe, Amanda, Vargas, Maria D., Tanaka, Marcelo N., Garcia, Flavio, Ronconi, Célia M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:An alternating magnetic field (AMF)-responsive controlled release system has been developed by the binding of mono-6-deoxy-6-( p -tolylsulfonyl)-β-cyclodextrin (βCD-Ts) onto amine-modified superparamagnetic iron oxide nanoparticles (MNP-NH 2 ), resulting in a MNP-βCD nanocarrier. The structural, chemical and colloidal properties of the nanocarrier MNP-βCD were fully evaluated by several techniques. Doxorubicin hydrochloride (DOX), as a model anticancer drug, was loaded onto MNP-βCD resulting in MNP-βCD-DOX and the release process was investigated by varying the temperature (37 and 45 °C), pH (7.4 and 5.0) and presence of an AMF (with and without). DOX can interact with the negatively charged surface of MNP-βCD and also with the cavity of βCD forming inclusion complexes. Under acidic conditions, both the negatively charged surface of MNP-βCD and the ionizable groups of DOX are protonated and the interactions between DOX and the nanocarrier MNP-βCD are weakened, thus, accelerating drug release. Temperature increase can reduce the supramolecular interactions between DOX and the nanocarrier MNP-βCD, favoring DOX release. Thermo-induced burst release at 45 °C has been investigated either by applying an alternating magnetic field (AMF, f = 307 kHz) or heating the solution in a thermostatic cuvette holder. In the absence of an AMF at 45 °C and at the pH value of the lysosome (5.0), 92% of DOX was released into the solution within 6 h. Importantly, in an AMF, at 45 (±1) °C and pH = 5.0, the same percentage of DOX release was observed after 50 min. Furthermore, in vitro assays revealed that the unloaded MNP-βCD nanoparticles (100 μg mL −1 ) displayed negligible cytotoxicity against A549 human lung adenocarcinoma cells either in the absence or presence of an AMF ( H × f = 4.9 × 10 9 A m −1 s −1 ) applied for 30 min on the cells. In the presence of an AMF no macroscopic temperature variation was detected in the wells containing the cells incubated with DOX unloaded MNP-βCD nanoparticles. The same amount of DOX loaded nanoparticles (MNP-βCD-DOX) showed cytotoxicity only in the presence of an AMF ( H × f = 4.9 × 10 9 A m −1 s −1 applied for 30 min), inducing cell death. Also, no macroscopic temperature variation was detected; therefore, DOX release might be associated with local heating generated from the rotation movements of the nanoparticles (Brown relaxation) upon AMF application. Thus, the DOX loaded β-cyclodextrin-decorated superparamagnetic nanoparticles (MNP-βC
ISSN:1144-0546
1369-9261
DOI:10.1039/C7NJ02860A